B+
Bull case
20%
Probability
Target price
$264.73
Analysis reference price unavailable
Analysis 2025-09-27 · RankAlpha Sentiment AI
ABBV
AbbVieDNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Stronger-than-expected uptake for new immunology and oncology launches, sustained margins, and continued dividends and buybacks that lift multiples and total return.
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +6.9.
What can break
High debt levels / refinancing risk in adverse market
Momentum
46
Value
62
Sentiment
49
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $227.23 · Bull $264.73 · Bear $185.31Analysis 2025-09-27; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2025-09-27 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-09-10
Investment thesis
As of 2026-09-10
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $279.73
Why
Momentum46 · Δ7d -25.2
Value62 · Δ7d -0.0
Sentiment49 · Δ7d +6.9
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +6.9.
Contradictions & invalidation
- • High debt levels / refinancing risk in adverse market
- • Humira biosimilar market share and pricing pressure
- • Faster-than-expected Humira biosimilar erosion, negative late-stage readouts or regulatory delays, and margin contraction that compresses valuation multiples.
Catalyst clock
No dated catalyst is available.
Quarterly earnings / guidance update
Lead driver: Sentiment · See AI snapshot
Momentum
46
9% active weight
Current posture
7d trendSoftening
Δ7d
-25.2
Δ21d
-16.1
Value
62
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
0.0
Sentiment
49
62% active weight
Current posture
7d trendImproving
Δ7d
+6.9
Δ21d
+6.3
Why this grade
Composite grade D. Momentum 46.2 / Value 61.7 / Sentiment 48.5
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2025-09-27. Scenario method
Most likely
B
Base case
60%
Probability
Target price
$227.23
Analysis reference price unavailable
Analysis 2025-09-27 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$185.31
Analysis reference price unavailable
Analysis 2025-09-27 · RankAlpha Sentiment AI
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$442.36B
Beta
0.34
Shares Out
1.77B
P/E (TTM)
166.1
P/S (TTM)
6.52
P/FCF (TTM)
47.54
Rev YoY
+10.2%
EPS YoY
+288.0%
Gross Margin
+71.4%
Op Margin
+34.2%
Net Debt
$63.12B
Current Ratio
0.81
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data